Oxirenofindolizine-2,3-diol, octahydro-, (1aR,2R,2aR,3S,7aS)-(185899-26-7)
- Name: Oxirenofindolizine-2,3-diol, octahydro-, (1aR,2R,2aR,3S,7aS)-
- Synonyms:Oxireno[f]indolizine-2,3-diol,octahydro-, (1aR,2R,2aR,3S,7aS)- (9CI); Oxireno[f]indolizine-2,3-diol,octahydro-, [1aR-(1aa,2b,2ab,3a,7aa)]-
- Molecular Formula:C8H13 N O3
- Molecular Weight:171.19
- CAS Registry Number:185899-26-7
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.185899-26-7 Oxirenofindolizine-2,3-diol, octahydro-, (1aR,2R,2aR,3S,7aS)-
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)]
Other Product
- 185899-42-7/Propanoic acid, 2,2-dimethyl-, octahydro-1,6,8-trihydroxy-7-indolizinyl ester, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
- 185899-41-6/Propanoic acid, 2,2-dimethyl-, octahydro-1,6,8-tris(2,2,2-trichloroethoxy)carbonyloxy-7-indolizinyl ester, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
- 185899-40-5/Carbonic acid, octahydro-7-hydroxy-1,6,8-indolizinetriyl tris(2,2,2-trichloroethyl) ester, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
- 185899-39-2/1,6,8-Indolizinetriol, 7-chlorooctahydro-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
- 185899-38-1/1,6,8-Indolizinetriol, 7-chlorooctahydro-, triacetate (ester), 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
- 185899-37-0/1,6,8-Indolizinetriol, 7-aminooctahydro-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
- 185899-35-8/Spirocyclohexane-1,2-1,3dioxino4,5,6-hiindolizin-9-amine, 8-(1,1-dimethylethyl)dimethylsilyloxyoctahydro-, 3aS-(3a.alpha.,8.alpha.,9.beta.,9a.beta.,9b.alpha.)-
- 185899-34-7/Spirocyclohexane-1,2-1,3dioxino4,5,6-hiindolizine, 9-azido-8-(1,1-dimethylethyl)dimethylsilyloxyoctahydro-, (3aS,8S,9S,9aR,9bR)-
- 185899-33-6/Spirocyclohexane-1,2-1,3dioxino4,5,6-hiindolizin-9-ol, 8-(1,1-dimethylethyl)dimethylsilyloxyoctahydro-, methanesulfonate (ester), 3aS-(3a.alpha.,8.alpha.,9.alpha.,9a.beta.,9b.alpha.)-
- 185899-32-5/Spirocyclohexane-1,2-1,3dioxino4,5,6-hiindolizin-9-ol, 8-(1,1-dimethylethyl)dimethylsilyloxyoctahydro-, 3aS-(3a.alpha.,8.alpha.,9.alpha.,9a.beta.,9b.alpha.)-
- 185899-31-4/1,6,7,8-Indolizinetetrol, octahydro-, 1,6,8-triacetate 7-methanesulfonate, 1S-(1.alpha.,6.beta.,7.beta.,8.beta.,8a.beta.)-
- 185899-30-3/Acetamide, N-1,6,8-tris(acetyloxy)octahydro-7-indolizinyl-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
- 185899-29-0/7(1H)-Indolizinone, 1,6,8-tris(acetyloxy)hexahydro-, 7-(O-methyloxime), 1S-(1.alpha.,6.beta.,8.beta.,8a.beta.)-
- 185899-28-9/Acetamide, N-(octahydro-1,6,8-trihydroxy-7-indolizinyl)-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
- 185899-27-8/Oxirenofindolizine-6,7-diol, octahydro-, diacetate (ester), 1aS-(1a.alpha.,6.alpha.,6a.beta.,7.beta.,7a.alpha.)-
- 185899-26-7/Oxirenofindolizine-2,3-diol, octahydro-, (1aR,2R,2aR,3S,7aS)-
- 185899-25-6/1,6,7,8-Indolizinetetrol, octahydro-, 1S-(1.alpha.,6.beta.,7.beta.,8.beta.,8a.beta.)-
- 185899-24-5/1,6,7,8-Indolizinetetrol, octahydro-7-methyl-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)-
- 185899-22-3/1,6,7,8-Indolizinetetrol, octahydro-7-methyl-, (1S,6S,7S,8R,8aR)-
- 185899-20-1/1,6,7,8-Indolizinetetrol, octahydro-7-methyl-, 1,6,8-triacetate, 1S-(1.alpha.,6.beta.,7.beta.,8.beta.,8a.beta.)-
- 185899-18-7/7(1H)-Indolizinone, 1,6,8-tris(acetyloxy)hexahydro-, 1S-(1.alpha.,6.beta.,8.beta.,8a.beta.)-
- 185898-93-5/Benzeneethanol, 2-(chloromethyl)- (9CI)
- 185898-84-4/Cyclopentanone, 3,4-dichloro-, trans- (9CI)
- 185897-02-3/Indinavir-D-6
- 185856-19-3/8-Indolizinecarboxylicacid,6-amino-1,2,3,5-tetrahydro-5-oxo-(9CI)
- 185848-10-6/1-(4-METHOXYPHENYL)-2-PYRIMIDIN-4-YLETHANOL
- 185843-78-1/1-Propanone, 2-chloro-1-(5-fluoro-2,4-dihydroxyphenyl)- (9CI)
- 185840-25-9/Benzofuro[3,2-e]benzothiazole (9CI)
- 185840-21-5/6H-1,3,5-Trioxepino[6,7-f]benzimidazole(9CI)
- 185840-01-1/BENZOTHIAZOLIUM, 2-[2-[2-(DIPHENYLAMINO)-3-[[3-(3-SULFOPROPYL)-2(3H)-BENZOTHIAZOLYLIDENE]ETHYLIDENE]-1-CYCLOPENTEN-1-YL]ETHENYL]-3-(3-SULFOPROPYL)-, INNER SALT, N,N-DIETHYLETHANAMINE (1:1)